Miyoshi Tomohiro, Tane Kenta, Samejima Joji, Aokage Keiju, Tsuboi Masahiro
Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Gen Thorac Cardiovasc Surg. 2024 Mar;72(3):183-191. doi: 10.1007/s11748-023-01968-x. Epub 2023 Sep 7.
This study aimed to identify the predictive factors for the progression of residual simultaneous multifocal ground-glass nodules (SMGGNs) after resection of the dominant lesion.
Patients (n = 3420) with primary lung cancer who underwent lung resections at our hospital between 2006 and 2016 were screened, and the data from 82 patients who had residual SMGGNs after undergoing surgery for the dominant lesion (pathologically stage 0-IIA) were retrospectively analyzed. Clinicopathological factors that predicted the growth of residual second dominant GGNs were identified.
Median total tumor and solid component sizes of the residual second dominant GGNs were 1.3 cm (interquartile range [IQR]: 0.6-2.0) and 0 cm (IQR: 0-0.7), respectively. During a median follow-up period of 54 months (IQR: 37-78 months), 35 (43%) lesions progressed. Logistic regression analysis revealed that age younger than 70 (OR: 10.54, 95% CI: 1.71-65.11), a dominant lesion with pure solid appearance (reference: GGN, OR: 18.16, 95% CI: 1.66-198.60), a second dominant GGN total size larger than 1.0 cm (OR: 12.27, 95% CI: 1.85-81.17), and a second dominant GGN solid component size larger than 0.5 cm (OR: 17.59, 95% CI: 3.58-86.47) were significant predictive factors for the progression of residual GGNs (all p values < 0.03). Based on an analysis of growth patterns, rapid growth was higher in second dominant GGNs with a part-solid appearance.
If the resected dominant lesion or the residual second dominant GGN exhibits high-risk factors, the second dominant GGN should be meticulously observed.
本研究旨在确定切除主要病灶后残留的同时性多灶性磨玻璃结节(SMGGNs)进展的预测因素。
筛选2006年至2016年间在我院接受肺切除术的原发性肺癌患者(n = 3420),并对82例在接受主要病灶手术(病理分期为0-IIA)后有残留SMGGNs的患者数据进行回顾性分析。确定预测残留的第二大主要磨玻璃结节(GGN)生长的临床病理因素。
残留的第二大主要GGN的肿瘤总大小和实性成分大小的中位数分别为1.3 cm(四分位间距[IQR]:0.6-2.0)和0 cm(IQR:0-0.7)。在中位随访期54个月(IQR:37-78个月)内,35个(43%)病灶进展。逻辑回归分析显示,年龄小于70岁(比值比[OR]:10.54,95%置信区间[CI]:1.71-65.11)、主要病灶为纯实性外观(参照:GGN,OR:18.16,95%CI:1.66-198.60)、第二大主要GGN总大小大于1.0 cm(OR:12.27,95%CI:1.85-81.17)以及第二大主要GGN实性成分大小大于0.5 cm(OR:17.59,95%CI:3.58-86.47)是残留GGN进展的显著预测因素(所有p值<0.03)。基于生长模式分析,部分实性外观的第二大主要GGN快速生长的比例更高。
如果切除的主要病灶或残留的第二大主要GGN具有高危因素,则应仔细观察第二大主要GGN。